Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)
Q4 2016 Earnings Call
February 13, 2017 8:00 am ET
Executives
Kevin C. Mannix - Teva Pharmaceutical Industries Ltd.
Sol J. Barer - Teva Pharmaceutical Industries Ltd.
Yitzhak Peterburg - Teva Pharmaceutical Industries Ltd.
Eyal Desheh - Teva Pharmaceutical Industries Ltd.
Robert Koremans - Teva Pharmaceutical Industries Ltd.
Dipankar Bhattacharjee - Teva Pharmaceutical Industries Ltd.
Michael R. Hayden - Teva Pharmaceutical Industries Ltd.
Analysts
Gregg Gilbert - Deutsche Bank Securities, Inc.
Elliot Wilbur - Raymond James & Associates, Inc.
Randall S. Stanicky - RBC Capital Markets LLC
Christopher Schott - JPMorgan Securities LLC
Liav Abraham - Citigroup Global Markets, Inc.
Ami Fadia - UBS Securities LLC
Ken Cacciatore - Cowen & Co. LLC
Umer Raffat - Evercore Group LLC
Jami Rubin - Goldman Sachs & Co.
David Maris - Wells Fargo Securities LLC
Louise Chen - Guggenheim Securities LLC
Aaron Gal, Ph.D. - Sanford C. Bernstein & Co. LLC
